| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | NPM1 TPR ARID1B CENPB RBL2 UBTF SUPT16H NAP1L1 APBB1 APP ATAD2 SIRT1 TOP2B NPM2 BAP1 POLR3G | 1.07e-07 | 739 | 87 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | histone binding | 2.33e-07 | 265 | 87 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DCAF1 NPM1 TPR MAPK8IP1 ARID1B TONSL STRN4 APBB1 PEX14 TAF9 TNNT2 PRDM16 MIER1 SIRT1 MAPK8IP2 | 1.35e-04 | 1160 | 87 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | histone modifying activity | 4.96e-04 | 229 | 87 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZSCAN29 HOXA7 MYCN HIVEP3 SOX11 BPTF GTF2A1 ZBTB33 ZBTB7C DMRT2 RBL2 ZKSCAN2 APP PRDM16 CASZ1 SIRT1 | 5.09e-04 | 1459 | 87 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | molecular adaptor activity | DCAF1 NPM1 TPR MAPK8IP1 ARID1B TONSL STRN4 APBB1 PEX14 TAF9 TNNT2 PRDM16 MIER1 SIRT1 MAPK8IP2 | 7.13e-04 | 1356 | 87 | 15 | GO:0060090 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 MYCN NPM1 TPR BPTF GTF2A1 ARID1B BAZ2B RBL2 UBTF TONSL SUPT16H NAP1L1 APBB1 APP TAF9 ATAD2 PRDM16 MIER1 SIRT1 NPM2 BAP1 | 6.47e-11 | 999 | 85 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | DCAF1 MYCN NPM1 TPR BPTF ARID1B BAZ2B RBL2 TONSL SUPT16H NAP1L1 APBB1 APP TAF9 ATAD2 PRDM16 MIER1 SIRT1 NPM2 BAP1 | 4.49e-10 | 896 | 85 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | DCAF1 MYCN NPM1 TPR BPTF ARID1B BAZ2B SUPT16H NAP1L1 APBB1 APP TAF9 ATAD2 PRDM16 MIER1 SIRT1 NPM2 BAP1 | 1.02e-09 | 741 | 85 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MYCN SOX11 TTBK1 NRDC HAP1 ABCC8 NAP1L1 ROBO2 AFDN RAPGEF2 CASZ1 | 8.51e-06 | 515 | 85 | 11 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | TAOK2 NPM1 TPR ARID1B RBL2 ANAPC15 ECD APBB1 PPP1R9B APP NPM2 | 8.67e-06 | 516 | 85 | 11 | GO:1901987 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MYCN SOX11 TTBK1 NRDC HAP1 ABCC8 NAP1L1 ROBO2 AFDN RAPGEF2 APP CASZ1 | 9.42e-06 | 625 | 85 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 1.10e-05 | 184 | 85 | 7 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | TAOK2 NPM1 TPR ARID1B TTBK1 IPO7 ALMS1 RBL2 ANAPC15 ECD APBB1 PPP1R9B APP SIRT1 PPM1G NPM2 BAP1 | 1.21e-05 | 1256 | 85 | 17 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | TAOK2 NPM1 TPR ARID1B ALMS1 RBL2 ANAPC15 ECD APBB1 PPP1R9B APP SIRT1 NPM2 | 4.03e-05 | 845 | 85 | 13 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 4.14e-05 | 402 | 85 | 9 | GO:1901990 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HOXA7 MYCN NPM1 SOX11 BPTF GTF2A1 PAXBP1 ZBTB7C DMRT2 ECD APBB1 NCL APP TAF9 PRDM16 CASZ1 SIRT1 | 4.41e-05 | 1390 | 85 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | TAOK2 NPM1 TPR ARID1B RBL2 ANAPC15 ECD APBB1 PPP1R9B APP NPM2 | 5.21e-05 | 627 | 85 | 11 | GO:0044770 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | HOXA7 MYCN SOX11 IPO7 LBX1 ABCC8 DACT3 APBB1 RAPGEF2 APP PRDM16 CASZ1 SIRT1 | 5.75e-05 | 875 | 85 | 13 | GO:0045596 |
| GeneOntologyBiologicalProcess | neuron projection development | TAOK2 ARID1B ALMS1 CELSR2 NRDC SPOCK1 HAP1 APBB1 ROBO2 AFDN PPP1R9B RAPGEF2 APP SIRT1 TOP2B MAPK8IP2 | 6.21e-05 | 1285 | 85 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | dendrite development | 7.23e-05 | 335 | 85 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 7.61e-05 | 249 | 85 | 7 | GO:0065004 | |
| GeneOntologyBiologicalProcess | regulation of growth | TAOK2 DCAF1 NPM1 ALMS1 SPOCK1 OGFR DACT3 AFDN PPP1R9B APP SIRT1 BAP1 | 7.91e-05 | 777 | 85 | 12 | GO:0040008 |
| GeneOntologyBiologicalProcess | central nervous system development | MYCN SOX11 BPTF CLUAP1 TTBK1 CELSR2 LBX1 SPOCK1 HAP1 ROBO2 AFDN PPP1R9B RAPGEF2 APP TOP2B | 1.02e-04 | 1197 | 85 | 15 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of gliogenesis | 1.25e-04 | 62 | 85 | 4 | GO:0014014 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | HOXA7 MYCN SOX11 IPO7 ALMS1 LBX1 ABCC8 DACT3 APBB1 ROBO2 RAPGEF2 APP PRDM16 CASZ1 SIRT1 | 1.25e-04 | 1220 | 85 | 15 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of cell development | HOXA7 MYCN SOX11 ARID1B TTBK1 NRDC HAP1 ABCC8 NAP1L1 ROBO2 AFDN RAPGEF2 PRDM16 CASZ1 | 1.45e-04 | 1095 | 85 | 14 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 1.64e-04 | 594 | 85 | 10 | GO:0007346 | |
| GeneOntologyBiologicalProcess | positive regulation of cAMP-dependent protein kinase activity | 1.66e-04 | 5 | 85 | 2 | GO:2000481 | |
| GeneOntologyBiologicalProcess | positive regulation of relaxation of muscle | 1.66e-04 | 5 | 85 | 2 | GO:1901079 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SOX11 ARID1B TTBK1 ZBTB7C IPO7 NRDC HAP1 NAP1L1 ROBO2 AFDN RAPGEF2 APP PRDM16 SIRT1 | 2.22e-04 | 1141 | 85 | 14 | GO:0045597 |
| GeneOntologyBiologicalProcess | cell growth | 2.46e-04 | 625 | 85 | 10 | GO:0016049 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 2.47e-04 | 509 | 85 | 9 | GO:0044772 | |
| GeneOntologyBiologicalProcess | neuron development | TAOK2 ARID1B ALMS1 CELSR2 NRDC SPOCK1 HAP1 APBB1 ROBO2 AFDN PPP1R9B RAPGEF2 APP SIRT1 TOP2B MAPK8IP2 | 2.79e-04 | 1463 | 85 | 16 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cell growth | 2.85e-04 | 519 | 85 | 9 | GO:0001558 | |
| GeneOntologyBiologicalProcess | DNA repair | NPM1 ARID1B UVSSA TONSL SUPT16H APBB1 ASCC2 TAF9 SIRT1 TOP2B | 3.28e-04 | 648 | 85 | 10 | GO:0006281 |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 3.48e-04 | 7 | 85 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | regulation of gliogenesis | 4.03e-04 | 151 | 85 | 5 | GO:0014013 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | NPM1 TPR IPO7 CELSR2 HAP1 ABCC8 APBB1 HRC AFDN PPP1R9B APP TNNT2 SIRT1 BAP1 | 4.09e-04 | 1212 | 85 | 14 | GO:0060341 |
| GeneOntologyBiologicalProcess | DNA metabolic process | DCAF1 NPM1 ARID1B UVSSA TONSL SUPT16H NAP1L1 APBB1 ASCC2 TAF9 SIRT1 TOP2B NPM2 | 4.61e-04 | 1081 | 85 | 13 | GO:0006259 |
| GeneOntologyBiologicalProcess | regulation of endodeoxyribonuclease activity | 4.62e-04 | 8 | 85 | 2 | GO:0032071 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 5.93e-04 | 9 | 85 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 6.18e-04 | 94 | 85 | 4 | GO:0045665 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 6.37e-04 | 353 | 85 | 7 | GO:0010721 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 6.48e-04 | 354 | 85 | 7 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 6.51e-04 | 255 | 85 | 6 | GO:0045664 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 6.54e-04 | 464 | 85 | 8 | GO:0045786 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 7.28e-04 | 591 | 85 | 9 | GO:1903829 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 7.39e-04 | 362 | 85 | 7 | GO:0010948 | |
| GeneOntologyBiologicalProcess | regulation of deoxyribonuclease activity | 7.39e-04 | 10 | 85 | 2 | GO:0032070 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 7.48e-04 | 173 | 85 | 5 | GO:0050768 | |
| GeneOntologyBiologicalProcess | brain development | SOX11 BPTF TTBK1 CELSR2 HAP1 ROBO2 AFDN PPP1R9B RAPGEF2 APP TOP2B | 7.85e-04 | 859 | 85 | 11 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 7.91e-04 | 598 | 85 | 9 | GO:0080135 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 8.08e-04 | 176 | 85 | 5 | GO:1900180 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 9.02e-04 | 46 | 85 | 3 | GO:0009303 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 9.64e-04 | 275 | 85 | 6 | GO:0016072 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TAOK2 CELSR2 NRDC APBB1 ROBO2 AFDN RAPGEF2 APP TOP2B MAPK8IP2 | 9.96e-04 | 748 | 85 | 10 | GO:0048667 |
| GeneOntologyCellularComponent | chromatin | HOXA7 MYCN SOX11 BPTF ARID1B ZBTB33 DMRT2 CENPB LBX1 BAZ2B RBL2 TONSL SUPT16H NAP1L1 TAF9 CASZ1 SIRT1 TOP2B NPM2 | 1.20e-05 | 1480 | 89 | 19 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 TPR BPTF GTF2A1 ARID1B IPO7 CWC15 ANAPC15 POLR2F TONSL SUPT16H ASCC2 NCL RBM28 TAF9 SIRT1 BAP1 POLR3G | 1.67e-05 | 1377 | 89 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | growth cone lamellipodium | 5.36e-05 | 3 | 89 | 2 | GO:1990761 | |
| GeneOntologyCellularComponent | fibrillar center | 5.47e-05 | 156 | 89 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | growth cone | 8.49e-05 | 245 | 89 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.04e-04 | 253 | 89 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | growth cone filopodium | 1.07e-04 | 4 | 89 | 2 | GO:1990812 | |
| GeneOntologyCellularComponent | FACT complex | 1.07e-04 | 4 | 89 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TAOK2 VGF MAPK8IP1 BPTF TTBK1 FRMPD4 NRDC HAP1 STRN4 APBB1 AFDN PPP1R9B RAPGEF2 APP MAPK8IP2 | 1.98e-04 | 1228 | 89 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | main axon | 5.69e-04 | 89 | 89 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | dendritic spine | 5.90e-04 | 242 | 89 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 6.57e-04 | 247 | 89 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | dendritic growth cone | 1.15e-03 | 12 | 89 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | postsynapse | TAOK2 FRMPD4 SPOCK1 HAP1 STRN4 APBB1 ROBO2 AFDN PPP1R9B RAPGEF2 APP MAPK8IP2 | 1.24e-03 | 1018 | 89 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 1.39e-03 | 113 | 89 | 4 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 1.53e-03 | 116 | 89 | 4 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 1.68e-03 | 119 | 89 | 4 | GO:0030880 | |
| GeneOntologyCellularComponent | distal axon | 2.56e-03 | 435 | 89 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | RNA polymerase III complex | 2.62e-03 | 18 | 89 | 2 | GO:0005666 | |
| HumanPheno | Abnormal eating behavior | 5.29e-06 | 128 | 29 | 7 | HP:0100738 | |
| Domain | Nucleoplasmin_core_dom | 6.27e-05 | 3 | 86 | 2 | IPR024057 | |
| Domain | Nucleoplasmin | 6.27e-05 | 3 | 86 | 2 | PF03066 | |
| Domain | - | 6.27e-05 | 3 | 86 | 2 | 2.60.120.340 | |
| Domain | DDT | 1.25e-04 | 4 | 86 | 2 | PF02791 | |
| Domain | Nucleoplasmin | 1.25e-04 | 4 | 86 | 2 | IPR004301 | |
| Domain | DDT | 2.08e-04 | 5 | 86 | 2 | SM00571 | |
| Domain | WSD | 2.08e-04 | 5 | 86 | 2 | PF15613 | |
| Domain | DDT_dom | 2.08e-04 | 5 | 86 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 2.08e-04 | 5 | 86 | 2 | IPR028941 | |
| Domain | PID | 2.84e-04 | 28 | 86 | 3 | PF00640 | |
| Domain | DDT | 3.11e-04 | 6 | 86 | 2 | PS50827 | |
| Domain | PID | 4.25e-04 | 32 | 86 | 3 | PS01179 | |
| Domain | BROMODOMAIN_1 | 6.54e-04 | 37 | 86 | 3 | PS00633 | |
| Domain | Bromodomain | 7.08e-04 | 38 | 86 | 3 | PF00439 | |
| Domain | DUF1220 | 7.39e-04 | 9 | 86 | 2 | SM01148 | |
| Domain | PTB | 8.23e-04 | 40 | 86 | 3 | SM00462 | |
| Domain | PTB/PI_dom | 8.85e-04 | 41 | 86 | 3 | IPR006020 | |
| Domain | BROMODOMAIN_2 | 8.85e-04 | 41 | 86 | 3 | PS50014 | |
| Domain | BROMO | 9.50e-04 | 42 | 86 | 3 | SM00297 | |
| Domain | Bromodomain | 9.50e-04 | 42 | 86 | 3 | IPR001487 | |
| Domain | - | 9.50e-04 | 42 | 86 | 3 | 1.20.920.10 | |
| Domain | NBPF_dom | 1.12e-03 | 11 | 86 | 2 | IPR010630 | |
| Domain | NBPF | 1.12e-03 | 11 | 86 | 2 | PS51316 | |
| Domain | DUF1220 | 1.12e-03 | 11 | 86 | 2 | PF06758 | |
| Domain | ARM-like | 1.54e-03 | 270 | 86 | 6 | IPR011989 | |
| Domain | IMPORTIN_B_NT | 1.84e-03 | 14 | 86 | 2 | PS50166 | |
| Domain | IBN_N | 2.12e-03 | 15 | 86 | 2 | PF03810 | |
| Domain | IBN_N | 2.41e-03 | 16 | 86 | 2 | SM00913 | |
| Domain | Importin-beta_N | 2.72e-03 | 17 | 86 | 2 | IPR001494 | |
| Domain | - | 3.62e-03 | 222 | 86 | 5 | 1.25.10.10 | |
| Domain | PDZ | 4.10e-03 | 141 | 86 | 4 | PF00595 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 1.25e-05 | 70 | 61 | 5 | M27008 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 4.34e-05 | 149 | 61 | 6 | M4076 | |
| Pathway | REACTOME_HIV_INFECTION | 5.96e-05 | 231 | 61 | 7 | M12469 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 3.74e-04 | 79 | 61 | 4 | M66 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 4.12e-04 | 81 | 61 | 4 | M865 | |
| Pathway | SIG_CD40PATHWAYMAP | 4.19e-04 | 34 | 61 | 3 | M12705 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 4.52e-04 | 83 | 61 | 4 | MM15314 | |
| Pubmed | PDIA4 TNPO1 DCAF1 NPM1 FAM171A1 GTF2A1 PAXBP1 IPO7 UBTF CWC15 ECD SUPT16H APBB1 ASCC2 NCL CRYBG3 RBM28 APP SIRT1 TOP2B ESF1 PPM1G | 2.14e-11 | 1487 | 90 | 22 | 33957083 | |
| Pubmed | PDIA4 TNPO1 NPM1 TPR BPTF IPO7 UBTF NAP1L1 MAK16 AFDN NCL RBM28 ATAD2 ESF1 PPM1G | 1.35e-10 | 653 | 90 | 15 | 22586326 | |
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 3.87e-10 | 35 | 90 | 6 | 29104064 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 TPR CCDC43 GTF2A1 ZBTB33 ALMS1 UBTF CWC15 ECD NAP1L1 APBB1 PEX14 PPP1R9B NCL TOP2B ESF1 | 2.16e-09 | 934 | 90 | 16 | 33916271 |
| Pubmed | 2.79e-09 | 86 | 90 | 7 | 37253089 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NPM1 TPR BPTF ARID1B PAXBP1 ZBTB33 BAZ2B UBTF CWC15 SUPT16H AFDN NCL RBM28 TAF9 TOP2B ESF1 | 2.92e-09 | 954 | 90 | 16 | 36373674 |
| Pubmed | DCAF1 NPM1 BPTF UBE2R2 ARID1B ZBTB33 ALMS1 CENPB LBX1 SUPT16H ZKSCAN2 CRYBG3 RAPGEF2 APP TAF9 PRDM16 SIRT1 | 3.70e-09 | 1116 | 90 | 17 | 31753913 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TNPO1 DCAF1 NPM1 BPTF OGFR UBTF SUPT16H NAP1L1 MAK16 NCL RBM28 TAF9 ATAD2 TOP2B ESF1 PPM1G | 4.86e-09 | 989 | 90 | 16 | 36424410 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZSCAN29 NPM1 BPTF PAXBP1 BAZ2B UBTF CWC15 ANAPC15 POLR2F TONSL SUPT16H NCL RBM28 TAF9 MIER1 CASZ1 TOP2B BAP1 | 4.97e-09 | 1294 | 90 | 18 | 30804502 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.70e-09 | 150 | 90 | 8 | 28242625 | |
| Pubmed | 2.04e-08 | 12 | 90 | 4 | 16301330 | ||
| Pubmed | 3.77e-08 | 191 | 90 | 8 | 20195357 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.47e-08 | 283 | 90 | 9 | 30585729 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BPTF IPO7 BAZ2B UBTF SUPT16H ATAD2 MIER1 CASZ1 SIRT1 TOP2B PPM1G BAP1 | 5.80e-08 | 608 | 90 | 12 | 36089195 |
| Pubmed | PDIA4 TNPO1 NPM1 TPR BPTF IPO7 ALMS1 OGFR SUPT16H NAP1L1 NCL | 6.44e-08 | 494 | 90 | 11 | 26831064 | |
| Pubmed | Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. | 6.69e-08 | 4 | 90 | 3 | 18480379 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 22362753 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.22e-07 | 148 | 90 | 7 | 32538781 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TNPO1 NPM1 TPR IPO7 UBTF CWC15 ECD SUPT16H NAP1L1 MAK16 ASCC2 PPP1R9B NCL RBM28 ESF1 PPM1G | 1.34e-07 | 1257 | 90 | 16 | 36526897 |
| Pubmed | Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex. | 1.67e-07 | 5 | 90 | 3 | 17719230 | |
| Pubmed | ABH2 couples regulation of ribosomal DNA transcription with DNA alkylation repair. | 1.67e-07 | 5 | 90 | 3 | 23972994 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 11912189 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 12893827 | ||
| Pubmed | TAOK2 VGF NPM1 FAM171A1 TPR MAPK8IP1 CELSR2 SUPT16H STRN4 AFDN PPP1R9B NCL RAPGEF2 MAPK8IP2 | 1.82e-07 | 963 | 90 | 14 | 28671696 | |
| Pubmed | TPR CCDC43 BPTF ARID1B ZBTB33 ALMS1 STRN4 NAP1L1 APBB1 AFDN ESF1 | 1.85e-07 | 549 | 90 | 11 | 38280479 | |
| Pubmed | 2.12e-07 | 332 | 90 | 9 | 25693804 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.20e-07 | 440 | 90 | 10 | 34244565 | |
| Pubmed | TAOK2 NPM1 TPR MAPK8IP1 FRMPD4 CELSR2 OGFR STRN4 APBB1 AFDN PPP1R9B NCL CRYBG3 APP PPM1G | 2.25e-07 | 1139 | 90 | 15 | 36417873 | |
| Pubmed | 3.06e-07 | 251 | 90 | 8 | 28077445 | ||
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 19450526 | ||
| Pubmed | TNPO1 TPR BPTF IPO7 CENPB UBTF SUPT16H NAP1L1 NCL TAF9 SIRT1 TOP2B ESF1 PPM1G | 3.39e-07 | 1014 | 90 | 14 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDIA4 TNPO1 NPM1 TPR BPTF IPO7 UBTF SUPT16H NAP1L1 AFDN NCL RBM28 APP TOP2B | 3.81e-07 | 1024 | 90 | 14 | 24711643 |
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 11517249 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDIA4 TNPO1 NPM1 TPR PAXBP1 IPO7 NRDC UBTF SUPT16H NAP1L1 MAK16 AFDN NCL ATAD2 TOP2B ESF1 | 7.12e-07 | 1425 | 90 | 16 | 30948266 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN TPR BPTF PAXBP1 AFDN NCL ATAD2 MIER1 SIRT1 TOP2B ESF1 BAP1 | 7.60e-07 | 774 | 90 | 12 | 15302935 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.98e-07 | 202 | 90 | 7 | 33005030 | |
| Pubmed | 1.14e-06 | 206 | 90 | 7 | 22174317 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDIA4 TNPO1 DCAF1 RNGTT IPO7 NRDC ECD AFDN NCL RBM28 TAF9 SIRT1 PPM1G | 1.35e-06 | 974 | 90 | 13 | 28675297 |
| Pubmed | 1.51e-06 | 215 | 90 | 7 | 35973513 | ||
| Pubmed | 1.65e-06 | 425 | 90 | 9 | 24999758 | ||
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.76e-06 | 220 | 90 | 7 | 34091597 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.76e-06 | 220 | 90 | 7 | 35785414 | |
| Pubmed | PDIA4 TNPO1 NPM1 FAM171A1 TPR CCDC43 ZBTB33 IPO7 AFDN CRYBG3 PPM1G | 2.23e-06 | 708 | 90 | 11 | 39231216 | |
| Pubmed | 2.58e-06 | 449 | 90 | 9 | 31732153 | ||
| Pubmed | 2.97e-06 | 340 | 90 | 8 | 29478914 | ||
| Pubmed | UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | 3.25e-06 | 155 | 90 | 6 | 34921745 | |
| Pubmed | 3.67e-06 | 469 | 90 | 9 | 27634302 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.75e-06 | 351 | 90 | 8 | 38297188 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 4.05e-06 | 91 | 90 | 5 | 34780483 | |
| Pubmed | 4.21e-06 | 251 | 90 | 7 | 31076518 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NPM1 BPTF RNGTT CENPB UBTF SUPT16H MAK16 NCL RBM28 TOP2B ESF1 | 4.33e-06 | 759 | 90 | 11 | 35915203 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDIA4 TNPO1 NPM1 GTF2A1 UBE2R2 IPO7 NRDC GON7 OGFR SUPT16H STRN4 NAP1L1 NCL SIRT1 PPM1G | 4.69e-06 | 1455 | 90 | 15 | 22863883 |
| Pubmed | A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis. | 4.70e-06 | 13 | 90 | 3 | 32929379 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 5.17e-06 | 259 | 90 | 7 | 30404004 | |
| Pubmed | PDIA4 BPTF ARID1B RNGTT IPO7 BAZ2B UBTF NAP1L1 RBM28 TAF9 SIRT1 TOP2B PPM1G | 5.24e-06 | 1103 | 90 | 13 | 34189442 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 2100262 | ||
| Pubmed | Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo. | 6.62e-06 | 2 | 90 | 2 | 21103325 | |
| Pubmed | AML-associated mutation of nucleophosmin compromises its interaction with nucleolin. | 6.62e-06 | 2 | 90 | 2 | 30130654 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32234886 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12653567 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15647266 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 28323844 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25348016 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 9799084 | ||
| Pubmed | Alzheimer's Amyloid-β Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells. | 6.62e-06 | 2 | 90 | 2 | 38397428 | |
| Pubmed | Requirement of JIP scaffold proteins for NMDA-mediated signal transduction. | 6.62e-06 | 2 | 90 | 2 | 17875667 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19564410 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18468999 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21310483 | ||
| Pubmed | C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. | 6.62e-06 | 2 | 90 | 2 | 8620867 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 34017061 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12209603 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17383198 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11724784 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17121854 | ||
| Pubmed | Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. | 6.62e-06 | 2 | 90 | 2 | 10075692 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20133016 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20713446 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 1903428 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 39013462 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11085987 | ||
| Pubmed | Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. | 6.62e-06 | 2 | 90 | 2 | 18833287 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25165140 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12023290 | ||
| Pubmed | [Features of the Structure and Expression of NPM and NCL Genes in Cutaneous Melanoma]. | 6.62e-06 | 2 | 90 | 2 | 31397440 | |
| Pubmed | Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain. | 6.62e-06 | 2 | 90 | 2 | 17855370 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10503877 | ||
| Pubmed | CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. | 6.75e-06 | 101 | 90 | 5 | 34462429 | |
| Pubmed | 7.45e-06 | 15 | 90 | 3 | 20205790 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 ZBTB33 IPO7 NRDC CENPB SUPT16H STRN4 PPP1R9B TAF9 SIRT1 PPM1G BAP1 | 1.10e-05 | 1005 | 90 | 12 | 19615732 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PDIA4 TNPO1 NPM1 TPR ECD POLR2F NAP1L1 NCL RBM28 MTERF4 PPM1G | 1.21e-05 | 847 | 90 | 11 | 35235311 |
| Pubmed | 1.34e-05 | 418 | 90 | 8 | 35338135 | ||
| Pubmed | 1.36e-05 | 419 | 90 | 8 | 15635413 | ||
| Pubmed | 1.58e-05 | 19 | 90 | 3 | 21489275 | ||
| Pubmed | 1.58e-05 | 19 | 90 | 3 | 15529118 | ||
| Pubmed | 1.63e-05 | 121 | 90 | 5 | 22412018 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.64e-05 | 430 | 90 | 8 | 38172120 | |
| Pubmed | PDIA4 FAM171A1 ARID1B RNGTT IPO7 UBTF SUPT16H PPP1R9B CRYBG3 APP ESF1 PPM1G | 1.68e-05 | 1049 | 90 | 12 | 27880917 | |
| Pubmed | 1.84e-05 | 210 | 90 | 6 | 16565220 | ||
| Pubmed | Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma. | 1.98e-05 | 3 | 90 | 2 | 35255831 | |
| Interaction | SIRT7 interactions | PDIA4 TNPO1 DCAF1 NPM1 TPR BPTF UBE2R2 IPO7 UBTF NAP1L1 MAK16 AFDN NCL RBM28 APP ATAD2 SIRT1 ESF1 PPM1G | 4.77e-10 | 744 | 89 | 19 | int:SIRT7 |
| Interaction | POLR1G interactions | MYCN NPM1 BPTF RNGTT BAZ2B UBTF POLR2F SUPT16H NCL SNX21 RBM28 TOP2B ESF1 PPM1G BAP1 | 3.54e-09 | 489 | 89 | 15 | int:POLR1G |
| Interaction | RPL36AL interactions | DCAF1 MYCN NPM1 RNGTT IPO7 DRICH1 NRDC NAP1L1 MAK16 PPP1R9B RBM28 PPM1G | 1.13e-08 | 309 | 89 | 12 | int:RPL36AL |
| Interaction | MACROH2A1 interactions | TNPO1 DCAF1 MYCN NPM1 BPTF CENPB TONSL SUPT16H NAP1L1 PPP1R9B ERICH2 NCL APP PRDM16 | 1.30e-08 | 458 | 89 | 14 | int:MACROH2A1 |
| Interaction | CSNK2A2 interactions | MYCN NPM1 GTF2A1 UBE2R2 CLUAP1 RNGTT RBL2 POLR2F SUPT16H STRN4 NAP1L1 MAK16 NCL PRDM16 SIRT1 PPM1G BAP1 | 1.37e-08 | 718 | 89 | 17 | int:CSNK2A2 |
| Interaction | SNRNP40 interactions | MYCN NPM1 ARID1B PAXBP1 RNGTT BAZ2B UBTF CWC15 ECD TONSL SUPT16H MAK16 RBM28 APP ATAD2 TOP2B | 1.71e-08 | 637 | 89 | 16 | int:SNRNP40 |
| Interaction | PES1 interactions | MYCN NPM1 CENPB UBTF SUPT16H NAP1L1 NCL RBM28 APP SIRT1 ESF1 | 1.85e-08 | 258 | 89 | 11 | int:PES1 |
| Interaction | CSNK2A1 interactions | MYCN NPM1 GTF2A1 UBE2R2 RNGTT RBL2 UBTF ECD POLR2F SUPT16H NAP1L1 MAK16 NCL APP ATAD2 PRDM16 SIRT1 ESF1 BAP1 | 2.85e-08 | 956 | 89 | 19 | int:CSNK2A1 |
| Interaction | POLR1E interactions | MYCN BAZ2B UBTF POLR2F SUPT16H NCL RBM28 CASZ1 SIRT1 TOP2B ESF1 PPM1G | 4.46e-08 | 350 | 89 | 12 | int:POLR1E |
| Interaction | H3-4 interactions | TNPO1 DCAF1 NPM1 BPTF TONSL NCL RAPGEF2 TAF9 ATAD2 PRDM16 MIER1 SIRT1 PPM1G | 8.25e-08 | 448 | 89 | 13 | int:H3-4 |
| Interaction | BRCA1 interactions | PDIA4 TNPO1 MYCN NPM1 TPR BPTF RNGTT IPO7 ALMS1 CENPB RBL2 OGFR UBTF TONSL SUPT16H NAP1L1 PPP1R9B NCL RBM28 TOP2B BAP1 | 8.26e-08 | 1249 | 89 | 21 | int:BRCA1 |
| Interaction | DNAJC17 interactions | 1.39e-07 | 134 | 89 | 8 | int:DNAJC17 | |
| Interaction | H2AC20 interactions | MYCN NPM1 TONSL SUPT16H NAP1L1 NCL RBM28 APP MIER1 PPM1G BAP1 | 1.65e-07 | 320 | 89 | 11 | int:H2AC20 |
| Interaction | NOP56 interactions | PDIA4 MYCN NPM1 UBTF SUPT16H NAP1L1 PPP1R9B NCL RBM28 PRDM16 TOP2B ESF1 PPM1G BAP1 | 1.94e-07 | 570 | 89 | 14 | int:NOP56 |
| Interaction | RPL31 interactions | MYCN NPM1 IPO7 UBTF UVSSA SUPT16H NAP1L1 MAK16 NCL RBM28 APP TOP2B ESF1 PPM1G BAP1 | 2.70e-07 | 680 | 89 | 15 | int:RPL31 |
| Interaction | HDAC1 interactions | DCAF1 MYCN NPM1 TPR BPTF ZBTB33 ALMS1 RBL2 UBTF APBB1 ASCC2 PEX14 CRYBG3 PRDM16 MIER1 CASZ1 SIRT1 TOP2B BAP1 | 2.86e-07 | 1108 | 89 | 19 | int:HDAC1 |
| Interaction | KPNA2 interactions | TNPO1 MYCN ZBTB33 RNGTT IPO7 HAP1 POLR2F APP PRDM16 SIRT1 PPM1G BAP1 POLR3G | 4.45e-07 | 519 | 89 | 13 | int:KPNA2 |
| Interaction | SUPT4H1 interactions | 5.03e-07 | 67 | 89 | 6 | int:SUPT4H1 | |
| Interaction | SRPK2 interactions | MYCN NPM1 PAXBP1 ALMS1 UBTF SUPT16H MAK16 PPP1R9B NCL RBM28 APP TOP2B PPM1G NPM2 BAP1 | 5.29e-07 | 717 | 89 | 15 | int:SRPK2 |
| Interaction | NUP43 interactions | DCAF1 NPM1 BPTF ARID1B PAXBP1 BAZ2B UBTF TONSL SUPT16H MAK16 RBM28 RAPGEF2 ATAD2 TOP2B | 5.89e-07 | 625 | 89 | 14 | int:NUP43 |
| Interaction | SIRT6 interactions | NPM1 ARID1B RNGTT CELSR2 UBTF ANAPC15 TONSL SUPT16H ASCC2 PEX14 NCL RBM28 TOP2B ESF1 | 6.24e-07 | 628 | 89 | 14 | int:SIRT6 |
| Interaction | DNAJC8 interactions | 8.09e-07 | 230 | 89 | 9 | int:DNAJC8 | |
| Interaction | CENPA interactions | NPM1 BPTF IPO7 CENPB UBTF SUPT16H ATAD2 CASZ1 TOP2B ESF1 PPM1G | 8.41e-07 | 377 | 89 | 11 | int:CENPA |
| Interaction | UTP4 interactions | 8.59e-07 | 170 | 89 | 8 | int:UTP4 | |
| Interaction | H2AC17 interactions | 8.69e-07 | 232 | 89 | 9 | int:H2AC17 | |
| Interaction | COIL interactions | TNPO1 MYCN BAZ2B UBTF UVSSA SUPT16H RBM28 APP TAF9 CASZ1 SIRT1 TOP2B ESF1 | 8.89e-07 | 552 | 89 | 13 | int:COIL |
| Interaction | NAA40 interactions | NPM1 TPR CCDC43 GTF2A1 ZBTB33 ALMS1 UBTF CWC15 ECD SUPT16H NAP1L1 APBB1 PEX14 PPP1R9B NCL TOP2B ESF1 | 1.12e-06 | 978 | 89 | 17 | int:NAA40 |
| Interaction | HSPA4 interactions | PDIA4 DCAF1 MYCN NPM1 ALMS1 HAP1 PPP1R9B NCL CRYBG3 APP SIRT1 TOP2B PPM1G BAP1 | 1.27e-06 | 667 | 89 | 14 | int:HSPA4 |
| Interaction | H3C1 interactions | DCAF1 NPM1 TPR SOX11 BPTF UBTF TONSL SUPT16H NAP1L1 RBM28 TAF9 ATAD2 PRDM16 SIRT1 TOP2B PPM1G | 1.84e-06 | 901 | 89 | 16 | int:H3C1 |
| Interaction | PNKP interactions | 2.49e-06 | 137 | 89 | 7 | int:PNKP | |
| Interaction | IFI16 interactions | PDIA4 TPR IPO7 CENPB UBTF SUPT16H MAK16 NCL RBM28 APP ATAD2 TOP2B ESF1 PPM1G | 2.82e-06 | 714 | 89 | 14 | int:IFI16 |
| Interaction | UHRF2 interactions | 2.90e-06 | 200 | 89 | 8 | int:UHRF2 | |
| Interaction | RPS24 interactions | DCAF1 MYCN NPM1 UBTF MAK16 NCL RBM28 TAF9 TOP2B ESF1 PPM1G BAP1 | 3.57e-06 | 529 | 89 | 12 | int:RPS24 |
| Interaction | PARP1 interactions | TNPO1 MYCN NPM1 BPTF CENPB UBTF ECD SUPT16H NAP1L1 NCL RBM28 ATAD2 PRDM16 CASZ1 SIRT1 TOP2B ESF1 PPM1G BAP1 | 3.75e-06 | 1316 | 89 | 19 | int:PARP1 |
| Interaction | NPM1 interactions | HOXA7 MYCN NPM1 TPR SUPT16H NAP1L1 MAK16 ASCC2 PPP1R9B NCL RBM28 APP SIRT1 TOP2B ESF1 PPM1G NPM2 BAP1 | 4.23e-06 | 1201 | 89 | 18 | int:NPM1 |
| Interaction | ZNF330 interactions | TNPO1 NPM1 IPO7 UBTF SUPT16H NAP1L1 NCL RBM28 TOP2B ESF1 PPM1G | 4.27e-06 | 446 | 89 | 11 | int:ZNF330 |
| Interaction | DNAJC9 interactions | 6.40e-06 | 296 | 89 | 9 | int:DNAJC9 | |
| Interaction | SMC5 interactions | NPM1 TPR BPTF ARID1B PAXBP1 ZBTB33 BAZ2B UBTF CWC15 SUPT16H AFDN NCL RBM28 TAF9 TOP2B ESF1 | 6.96e-06 | 1000 | 89 | 16 | int:SMC5 |
| Interaction | H2BC6 interactions | 7.96e-06 | 62 | 89 | 5 | int:H2BC6 | |
| Interaction | ZNF223 interactions | 8.92e-06 | 30 | 89 | 4 | int:ZNF223 | |
| Interaction | TOP1 interactions | DCAF1 MYCN NPM1 TPR RBL2 CWC15 SUPT16H NCL RBM28 APP PRDM16 TOP2B BAP1 | 1.12e-05 | 696 | 89 | 13 | int:TOP1 |
| Interaction | GTF3C1 interactions | 1.14e-05 | 241 | 89 | 8 | int:GTF3C1 | |
| Interaction | INA interactions | 1.16e-05 | 173 | 89 | 7 | int:INA | |
| Interaction | CHAF1A interactions | 1.26e-05 | 322 | 89 | 9 | int:CHAF1A | |
| Interaction | POLR3G interactions | 1.32e-05 | 33 | 89 | 4 | int:POLR3G | |
| Interaction | SLX9 interactions | 1.35e-05 | 177 | 89 | 7 | int:SLX9 | |
| Interaction | RCHY1 interactions | 1.35e-05 | 325 | 89 | 9 | int:RCHY1 | |
| Interaction | KPNA3 interactions | 1.41e-05 | 248 | 89 | 8 | int:KPNA3 | |
| Interaction | RPL5 interactions | TNPO1 MYCN NPM1 IPO7 SUPT16H NAP1L1 MAK16 NCL RBM28 PRDM16 TOP2B BAP1 | 1.41e-05 | 606 | 89 | 12 | int:RPL5 |
| Interaction | TCEANC2 interactions | 1.49e-05 | 34 | 89 | 4 | int:TCEANC2 | |
| Interaction | ESF1 interactions | 1.61e-05 | 182 | 89 | 7 | int:ESF1 | |
| Interaction | SP110 interactions | 1.68e-05 | 122 | 89 | 6 | int:SP110 | |
| Interaction | NUP50 interactions | 1.98e-05 | 341 | 89 | 9 | int:NUP50 | |
| Interaction | NIFK interactions | 2.03e-05 | 431 | 89 | 10 | int:NIFK | |
| Interaction | NAP1L1 interactions | 2.17e-05 | 345 | 89 | 9 | int:NAP1L1 | |
| Interaction | FBL interactions | MYCN NPM1 IPO7 UBTF SUPT16H NAP1L1 MAK16 NCL RBM28 TAF9 TOP2B ESF1 | 2.38e-05 | 639 | 89 | 12 | int:FBL |
| Interaction | RNF2 interactions | VGF MYCN ZBTB33 IPO7 CENPB OGFR UBTF SUPT16H PPP1R9B NCL RBM28 APP ESF1 NPM2 | 2.51e-05 | 866 | 89 | 14 | int:RNF2 |
| Interaction | SUZ12 interactions | VGF MYCN NPM1 BPTF PAXBP1 ALMS1 UBTF CWC15 SUPT16H PPP1R9B NCL SIRT1 | 2.57e-05 | 644 | 89 | 12 | int:SUZ12 |
| Interaction | DAXX interactions | 2.60e-05 | 353 | 89 | 9 | int:DAXX | |
| Interaction | RPS6 interactions | DCAF1 MYCN NPM1 IPO7 UBTF SUPT16H NAP1L1 MAK16 ASCC2 NCL RBM28 TOP2B ESF1 BAP1 | 2.77e-05 | 874 | 89 | 14 | int:RPS6 |
| Interaction | RPA4 interactions | 3.05e-05 | 452 | 89 | 10 | int:RPA4 | |
| Interaction | RPL35 interactions | DCAF1 MYCN NPM1 CLUAP1 IPO7 NAP1L1 MAK16 PPP1R9B NCL TOP2B BAP1 | 3.44e-05 | 558 | 89 | 11 | int:RPL35 |
| Interaction | SRP14 interactions | 3.45e-05 | 366 | 89 | 9 | int:SRP14 | |
| Interaction | LRRC31 interactions | 3.46e-05 | 205 | 89 | 7 | int:LRRC31 | |
| Interaction | SNRNP200 interactions | 3.54e-05 | 460 | 89 | 10 | int:SNRNP200 | |
| Interaction | H1-2 interactions | TAOK2 PDIA4 DCAF1 MYCN NPM1 IPO7 TONSL MAK16 PPP1R9B NCL APP BAP1 | 3.56e-05 | 666 | 89 | 12 | int:H1-2 |
| Interaction | GNL3 interactions | 3.60e-05 | 368 | 89 | 9 | int:GNL3 | |
| Interaction | CTCF interactions | 3.60e-05 | 461 | 89 | 10 | int:CTCF | |
| Interaction | C3orf49 interactions | 3.65e-05 | 15 | 89 | 3 | int:C3orf49 | |
| Interaction | H3C15 interactions | 3.68e-05 | 207 | 89 | 7 | int:H3C15 | |
| Interaction | EWSR1 interactions | PDIA4 TNPO1 MYCN NPM1 CCDC43 GTF2A1 UBTF CWC15 ECD TONSL SUPT16H SIRT1 PPM1G BAP1 | 4.11e-05 | 906 | 89 | 14 | int:EWSR1 |
| Interaction | MACROH2A2 interactions | 4.16e-05 | 211 | 89 | 7 | int:MACROH2A2 | |
| Interaction | NOG interactions | 4.61e-05 | 45 | 89 | 4 | int:NOG | |
| Interaction | ARL4D interactions | 4.62e-05 | 146 | 89 | 6 | int:ARL4D | |
| Interaction | DDX23 interactions | 5.06e-05 | 480 | 89 | 10 | int:DDX23 | |
| Interaction | C7orf50 interactions | 5.12e-05 | 218 | 89 | 7 | int:C7orf50 | |
| Interaction | EED interactions | TNPO1 DCAF1 MYCN NPM1 TPR BPTF IPO7 BAZ2B SUPT16H NAP1L1 MAK16 AFDN PPP1R9B NCL RBM28 ATAD2 CASZ1 SIRT1 | 5.13e-05 | 1445 | 89 | 18 | int:EED |
| Interaction | MDK interactions | 5.17e-05 | 91 | 89 | 5 | int:MDK | |
| Interaction | XRCC6 interactions | MYCN NPM1 TPR BPTF GTF2A1 ZBTB33 TONSL SUPT16H NCL PRDM16 TOP2B ESF1 PPM1G BAP1 | 5.33e-05 | 928 | 89 | 14 | int:XRCC6 |
| Interaction | USP7 interactions | MYCN TPR UBE2R2 ZBTB7C CENPB OGFR UBTF UVSSA SUPT16H NCL APP PRDM16 SIRT1 TOP2B PPM1G NPM2 BAP1 | 5.33e-05 | 1313 | 89 | 17 | int:USP7 |
| Interaction | SYT2 interactions | 5.38e-05 | 150 | 89 | 6 | int:SYT2 | |
| Interaction | POLR1A interactions | 5.42e-05 | 220 | 89 | 7 | int:POLR1A | |
| Interaction | BRF1 interactions | 5.45e-05 | 92 | 89 | 5 | int:BRF1 | |
| Interaction | SENP3 interactions | 5.59e-05 | 301 | 89 | 8 | int:SENP3 | |
| Interaction | NAT10 interactions | 5.72e-05 | 302 | 89 | 8 | int:NAT10 | |
| Interaction | RPL37A interactions | 5.75e-05 | 391 | 89 | 9 | int:RPL37A | |
| Interaction | H2AX interactions | PDIA4 NPM1 BPTF ARID1B TONSL SUPT16H NAP1L1 PPP1R9B NCL MIER1 PPM1G | 5.96e-05 | 593 | 89 | 11 | int:H2AX |
| Interaction | MRPL35 interactions | 6.04e-05 | 94 | 89 | 5 | int:MRPL35 | |
| Interaction | LRP2 interactions | 6.22e-05 | 154 | 89 | 6 | int:LRP2 | |
| Interaction | H3C3 interactions | 6.54e-05 | 495 | 89 | 10 | int:H3C3 | |
| Interaction | DCTN1 interactions | 6.76e-05 | 497 | 89 | 10 | int:DCTN1 | |
| Interaction | H2AC19 interactions | 7.01e-05 | 50 | 89 | 4 | int:H2AC19 | |
| Interaction | CMTM2 interactions | 7.66e-05 | 19 | 89 | 3 | int:CMTM2 | |
| Interaction | SEC62 interactions | 7.85e-05 | 506 | 89 | 10 | int:SEC62 | |
| Interaction | CUL7 interactions | PDIA4 TNPO1 MYCN NPM1 TPR BPTF UBTF SUPT16H NAP1L1 AFDN NCL APP TOP2B | 8.32e-05 | 845 | 89 | 13 | int:CUL7 |
| Interaction | CUL4B interactions | DCAF1 MYCN NPM1 TTBK1 UVSSA SUPT16H NAP1L1 APBB1 NCL APP SIRT1 BAP1 | 8.37e-05 | 728 | 89 | 12 | int:CUL4B |
| Interaction | ASPM interactions | 8.82e-05 | 164 | 89 | 6 | int:ASPM | |
| Interaction | CALR interactions | 8.90e-05 | 414 | 89 | 9 | int:CALR | |
| Interaction | PPP1R12A interactions | 8.95e-05 | 322 | 89 | 8 | int:PPP1R12A | |
| Interaction | SMARCA5 interactions | 9.07e-05 | 415 | 89 | 9 | int:SMARCA5 | |
| Cytoband | 1p13.3 | 3.48e-04 | 69 | 90 | 3 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 8.14e-04 | 211 | 90 | 4 | chr1p13 | |
| Cytoband | 21q21.3 | 8.56e-04 | 22 | 90 | 2 | 21q21.3 | |
| Cytoband | 1p36.22 | 2.42e-03 | 37 | 90 | 2 | 1p36.22 | |
| GeneFamily | Neuroblastoma breakpoint family | 5.30e-05 | 23 | 58 | 3 | 662 | |
| GeneFamily | PDZ domain containing | 1.43e-03 | 152 | 58 | 4 | 1220 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.50e-03 | 18 | 58 | 2 | 596 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 7.92e-10 | 90 | 89 | 8 | M39250 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP | 5.50e-06 | 200 | 89 | 7 | M7805 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | DCAF1 HIVEP3 NRDC CWC15 ANAPC15 UVSSA ECD PEX14 MIER1 SIRT1 TOP2B BAP1 | 1.81e-05 | 807 | 89 | 12 | M14594 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 2.89e-05 | 174 | 89 | 6 | M40888 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 3.64e-05 | 268 | 89 | 7 | M45696 | |
| Coexpression | MCCABE_HOXC6_TARGETS_DN | 4.82e-05 | 21 | 89 | 3 | M5465 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP | 5.95e-05 | 198 | 89 | 6 | M6106 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 6.11e-05 | 199 | 89 | 6 | M7259 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 7.74e-05 | 656 | 89 | 10 | M18979 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 9.30e-05 | 26 | 89 | 3 | M1380 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | DCAF1 MYCN NPM1 TPR MAPK8IP1 SOX11 GTF2A1 ZBTB33 RNGTT IPO7 ALMS1 CELSR2 POLR2F TONSL SUPT16H NAP1L1 MAK16 ERICH2 NCL ATAD2 SIRT1 ESF1 POLR3G | 2.89e-10 | 1164 | 89 | 23 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | DCAF1 MYCN NPM1 TPR MAPK8IP1 SOX11 GTF2A1 ZBTB33 RNGTT IPO7 ALMS1 CELSR2 POLR2F TONSL SUPT16H NAP1L1 MAK16 ERICH2 NCL ATAD2 SIRT1 ESF1 POLR3G | 4.82e-09 | 1347 | 89 | 23 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZSCAN29 DCAF1 NPM1 TPR BPTF GTF2A1 ZBTB33 RNGTT IPO7 ALMS1 NRDC CCDC34 SUPT16H NAP1L1 MAK16 NCL RAPGEF2 TAF9 ATAD2 PRDM16 SIRT1 ESF1 | 7.20e-09 | 1257 | 89 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZSCAN29 DCAF1 NPM1 TPR SOX11 BPTF GTF2A1 ZBTB33 RNGTT IPO7 ALMS1 NRDC CCDC34 SUPT16H NAP1L1 MAK16 NCL RAPGEF2 TAF9 ATAD2 PRDM16 SIRT1 ESF1 | 2.16e-08 | 1459 | 89 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | DCAF1 MYCN NPM1 TPR SOX11 GTF2A1 UBE2R2 ZBTB33 ALMS1 CELSR2 HAP1 CCDC34 NAP1L1 MAK16 NCL TNNT2 ATAD2 SIRT1 ESF1 POLR3G | 7.50e-07 | 1371 | 89 | 20 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | MYCN NPM1 MAPK8IP1 IPO7 CELSR2 HAP1 POLR2F NAP1L1 NCL MAPK8IP2 ESF1 POLR3G | 1.07e-06 | 496 | 89 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | DCAF1 MYCN MAPK8IP1 SOX11 PAXBP1 CELSR2 HAP1 MARCHF6 DACT3 APBB1 TAF9 PRDM16 MIER1 SIRT1 MAPK8IP2 | 1.27e-05 | 979 | 89 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | TNPO1 MYCN NPM1 MAPK8IP1 IPO7 CELSR2 HAP1 POLR2F SUPT16H NAP1L1 NCL RBM28 MAPK8IP2 ESF1 POLR3G | 1.46e-05 | 991 | 89 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAPK8IP1 SOX11 PAXBP1 CENPB HAP1 MARCHF6 APBB1 PRDM16 MAPK8IP2 | 1.62e-05 | 350 | 89 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.41e-05 | 204 | 89 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.89e-05 | 311 | 89 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | DCAF1 NPM1 TPR GTF2A1 ZBTB33 IPO7 ALMS1 CCDC34 TONSL SUPT16H MAK16 NCL TAF9 ATAD2 TOP2B ESF1 | 5.20e-05 | 1241 | 89 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DCAF1 MYCN NPM1 TPR SOX11 PAXBP1 HAP1 TONSL DACT3 NCL TAF9 PRDM16 SIRT1 ESF1 | 6.04e-05 | 989 | 89 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZSCAN29 MAPK8IP1 SOX11 ALMS1 RSPH4A HAP1 RBL2 CCDC34 MARCHF6 SUPT16H ZKSCAN2 PRDM16 MAPK8IP2 | 8.60e-05 | 893 | 89 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | DCAF1 MYCN NPM1 TPR GTF2A1 ZBTB33 IPO7 ALMS1 CCDC34 TONSL SUPT16H MAK16 NCL TAF9 ATAD2 TOP2B ESF1 | 1.11e-04 | 1468 | 89 | 17 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ZSCAN29 DCAF1 MYCN NPM1 TPR MAPK8IP1 SOX11 IPO7 ALMS1 CELSR2 SUPT16H PRDM16 SIRT1 ESF1 | 1.26e-04 | 1060 | 89 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.54e-04 | 469 | 89 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | ZSCAN29 DCAF1 MYCN TPR SOX11 BPTF UBE2R2 RNGTT ALMS1 CELSR2 HAP1 CCDC34 PRDM16 SIRT1 TOP2B ESF1 | 1.65e-04 | 1370 | 89 | 16 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZSCAN29 DCAF1 NPM1 TPR ZBTB33 IPO7 ALMS1 HAP1 SUPT16H NCL ATAD2 PRDM16 SIRT1 TOP2B ESF1 | 2.06e-04 | 1252 | 89 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 2.10e-04 | 489 | 89 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.25e-04 | 205 | 89 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | HIVEP3 TPR MAPK8IP1 SOX11 ALMS1 CELSR2 HAP1 CCDC34 MARCHF6 SUPT16H ZKSCAN2 PRDM16 MAPK8IP2 | 2.29e-04 | 986 | 89 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NPM1 SOX11 IPO7 ALMS1 CELSR2 HAP1 CCDC34 SUPT16H ZKSCAN2 NCL TOP2B MAPK8IP2 ESF1 | 2.36e-04 | 989 | 89 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.01e-04 | 629 | 89 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | MYCN NPM1 SOX11 GTF2A1 ZBTB33 IPO7 CELSR2 POLR2F NAP1L1 MAK16 NCL ATAD2 POLR3G | 5.47e-04 | 1080 | 89 | 13 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.58e-04 | 339 | 89 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | MYCN BPTF ARID1B PAXBP1 CELSR2 SPOCK1 BAZ2B CCDC34 HRC ZKSCAN2 CRYBG3 RBM28 MTERF4 CASZ1 | 6.48e-04 | 1245 | 89 | 14 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | DCAF1 MYCN PAXBP1 ANAPC15 DACT3 NAP1L1 APBB1 NCL TAF9 TNNT2 MIER1 SIRT1 | 8.04e-04 | 983 | 89 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.69e-04 | 595 | 89 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 8.90e-04 | 266 | 89 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 172 | 90 | 6 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-06 | 196 | 90 | 6 | f9a7d62684435f7c8a1205e2d0b2af0f6104a2dd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-05 | 160 | 90 | 5 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-05 | 164 | 90 | 5 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 168 | 90 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 168 | 90 | 5 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.33e-05 | 168 | 90 | 5 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 168 | 90 | 5 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 172 | 90 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 174 | 90 | 5 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 177 | 90 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 178 | 90 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 179 | 90 | 5 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 181 | 90 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 181 | 90 | 5 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 182 | 90 | 5 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 183 | 90 | 5 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.50e-05 | 183 | 90 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 183 | 90 | 5 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 184 | 90 | 5 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 184 | 90 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.69e-05 | 185 | 90 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 186 | 90 | 5 | 895905f1d1a01ffd5617a0baa8818693a7e9cb3b | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-05 | 94 | 90 | 4 | 56176a9435ef197f07034bbbd16b85016a89ad3c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.98e-05 | 188 | 90 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.29e-05 | 191 | 90 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 195 | 90 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.74e-05 | 195 | 90 | 5 | da8680a91648843901e456b5faef5e85039ade15 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 4.85e-05 | 196 | 90 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 4.85e-05 | 196 | 90 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-05 | 197 | 90 | 5 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-05 | 198 | 90 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.09e-05 | 198 | 90 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.86e-04 | 140 | 90 | 4 | 82b150e9e9962460a5cd6bef7ee04f28f5c05d1a | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.68e-04 | 154 | 90 | 4 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 2.68e-04 | 154 | 90 | 4 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 155 | 90 | 4 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 155 | 90 | 4 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-04 | 163 | 90 | 4 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.33e-04 | 163 | 90 | 4 | c1a98d6776b685f20dde049715233e5c73ce3244 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-04 | 167 | 90 | 4 | d041b345014e170e9a45f8c6ef8a37ff56f14750 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.73e-04 | 168 | 90 | 4 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 170 | 90 | 4 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.90e-04 | 170 | 90 | 4 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 173 | 90 | 4 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.35e-04 | 175 | 90 | 4 | df369b96a780272ed52e23c8627fc63c22efa445 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.35e-04 | 175 | 90 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-04 | 175 | 90 | 4 | 97a58bc6ed2e8e359283d4214172c990c6e3755e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 177 | 90 | 4 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 177 | 90 | 4 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.64e-04 | 178 | 90 | 4 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 179 | 90 | 4 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-04 | 180 | 90 | 4 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 4.94e-04 | 181 | 90 | 4 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-04 | 181 | 90 | 4 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-04 | 181 | 90 | 4 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 4.94e-04 | 181 | 90 | 4 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-04 | 182 | 90 | 4 | fa23d5bed1147a423c42bd30029a06963410b16e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-04 | 182 | 90 | 4 | cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-04 | 182 | 90 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-04 | 183 | 90 | 4 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 183 | 90 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.15e-04 | 183 | 90 | 4 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 183 | 90 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 184 | 90 | 4 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 184 | 90 | 4 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.26e-04 | 184 | 90 | 4 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 184 | 90 | 4 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 185 | 90 | 4 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 185 | 90 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 185 | 90 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 185 | 90 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 185 | 90 | 4 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-04 | 186 | 90 | 4 | 1094c7140131454b2583200e1c01e81ccab3db23 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-04 | 186 | 90 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.48e-04 | 186 | 90 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-04 | 186 | 90 | 4 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-04 | 186 | 90 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.48e-04 | 186 | 90 | 4 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-04 | 187 | 90 | 4 | 85645de9069bd9a8a02d53b0d3d73bf9c2b57189 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-04 | 187 | 90 | 4 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-04 | 188 | 90 | 4 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| Computational | Nuclear pore complex. | 9.61e-05 | 17 | 58 | 3 | MODULE_352 | |
| Computational | Neighborhood of PPP1CC | 2.27e-04 | 56 | 58 | 4 | GCM_PPP1CC | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A | 8.71e-07 | 192 | 89 | 8 | 1778_DN | |
| Drug | UF010 compound | 2.59e-06 | 25 | 89 | 4 | ctd:C000602704 | |
| Drug | 4-nitrobiphenyl | 4.16e-06 | 28 | 89 | 4 | CID000007114 | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.12e-05 | 194 | 89 | 7 | 1073_UP | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 7191_DN | |
| Drug | testosterone enanthate | TNPO1 HOXA7 TPR BPTF CLUAP1 RNGTT RBL2 OGFR RAPGEF2 APP ESF1 | 1.49e-05 | 575 | 89 | 11 | ctd:C004648 |
| Disease | Sinusitis | 1.71e-04 | 7 | 85 | 2 | C0037199 | |
| Disease | Todd Paralysis | 2.91e-04 | 9 | 85 | 2 | C0234544 | |
| Disease | Paralysed | 2.91e-04 | 9 | 85 | 2 | C0522224 | |
| Disease | cerebrospinal fluid biomarker measurement, alpha synuclein measurement | 3.64e-04 | 10 | 85 | 2 | EFO_0006794, EFO_0009323 | |
| Disease | Necrosis | 5.43e-04 | 55 | 85 | 3 | C0027540 | |
| Disease | response to statin | 5.73e-04 | 56 | 85 | 3 | GO_0036273 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 6.03e-04 | 57 | 85 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 6.27e-04 | 13 | 85 | 2 | C0265338 | |
| Disease | Left ventricular noncompaction | 7.30e-04 | 14 | 85 | 2 | C1960469 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 8.40e-04 | 15 | 85 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Huntington's disease (is_implicated_in) | 1.99e-03 | 23 | 85 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 2.55e-03 | 26 | 85 | 2 | C0206698 | |
| Disease | metabolic syndrome | 2.70e-03 | 200 | 85 | 4 | EFO_0000195 | |
| Disease | azoospermia (implicated_via_orthology) | 2.75e-03 | 27 | 85 | 2 | DOID:14227 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDNLEDFDVEEEDEE | 521 | Q13523 | |
| KDEDDEEEEDDDVDT | 1576 | P55196 | |
| EDDGEDDTNDEDDDE | 41 | A1L162 | |
| HYDDEEEEDDEDDED | 61 | P60006 | |
| EEEDDEDDEDSEEDS | 66 | P60006 | |
| EDDEDSEEDSEDDED | 71 | P60006 | |
| DDREAADEEEEEEEA | 2141 | Q68DQ2 | |
| EADDDEDDEDGDEVE | 241 | P05067 | |
| DDEDDDDEDLRTDSE | 1706 | Q86V15 | |
| DSDDQGDEDDEDEED | 1306 | Q9UIF8 | |
| GQEEDDDDEEDDADE | 656 | Q9H1I8 | |
| EEEDEEDKDADSLDE | 631 | Q86TY3 | |
| EEEEEEEEAAAAAAA | 21 | Q8TCU4 | |
| DDEDDYEDDEEDDVQ | 396 | Q92560 | |
| EEDDDDEEEEEDLSS | 161 | O00213 | |
| EEEDAECIDDDEEDE | 1801 | Q8NFD5 | |
| QEHEDDGEDEDDEDD | 251 | Q6PL18 | |
| DSEEEEEEEEEEAAF | 2741 | Q9HCU4 | |
| DEEDEDFEEESDDDD | 111 | Q9P013 | |
| DEEDEMEEDDDDSDY | 161 | Q12830 | |
| DDLDDEDFECLDSDD | 506 | O95905 | |
| NDEDEDEDEDDKDEE | 166 | Q96M43 | |
| VKLAADEDDDDDDEE | 156 | P06748 | |
| DDDDDFDDEEAEEKA | 176 | P06748 | |
| EDMEEEENDDDDDDD | 226 | Q9NW13 | |
| DDDDDDEEDGVFDDE | 236 | Q9NW13 | |
| EDLDGDDEDDAEDEN | 66 | Q9BXV9 | |
| AIEDDDDDYDEEGEE | 346 | P55209 | |
| SDEEEEDDGEAEDAA | 21 | Q08999 | |
| ADVTDEEDEADEKDD | 136 | Q96MW1 | |
| EDDDDTDDLDELDTD | 1416 | Q9Y4B6 | |
| AHEEEEDDDDDDQGE | 856 | Q5VUB5 | |
| DTEEKDDDDDDEEDV | 201 | Q9BXY0 | |
| DWCFEDDEDEDEDED | 191 | O60942 | |
| ANEEEEEEIIDDDDD | 326 | Q86T24 | |
| AEDDEEDDDEERAAR | 106 | Q9UQF2 | |
| ACSEEEDEEDDEEEE | 466 | Q13387 | |
| DEEEDEDEDSEDDDK | 281 | Q9H501 | |
| SDDDDEAEDDDETEE | 886 | O95373 | |
| DDQAEEEEEDNEEED | 226 | O60337 | |
| EDENDASDDEDDDEK | 256 | Q9Y5B6 | |
| EDDDDDEEDDSEEEA | 196 | P19338 | |
| NVAEDEDEEEDDEDE | 231 | P19338 | |
| DSDSEEEDDEEEDDE | 511 | P07199 | |
| EAEDEEDADEDEDAA | 56 | Q96B18 | |
| CEDDEDDDGVDEDAE | 46 | Q9Y5R5 | |
| DEEDVDDEEDVDEDA | 86 | Q96HJ3 | |
| DDEEDVDEDAHDSEA | 91 | Q96HJ3 | |
| DDAEDEDEVSCEEDL | 746 | Q14CM0 | |
| YSDSDEEDEDEEEEE | 256 | P54257 | |
| QDCSEDEEDEEIDVD | 266 | P52954 | |
| EEEEDDEDEDADISL | 141 | Q86SE8 | |
| EDDDCDDDDDDAQIL | 161 | Q6PGQ1 | |
| AAADKADEEDDDEEE | 211 | P31268 | |
| EEEEGEDDEDADNDD | 91 | Q8N108 | |
| EEDEEDAEDAEDEDC | 11 | Q9NZT2 | |
| ENEESEEDEDEEDDY | 701 | Q5TD94 | |
| RKREDDDDDDDDDDD | 246 | Q16594 | |
| FLDEDDDDDDDDDEL | 221 | P35716 | |
| LGDAEEDEDDEDFVE | 396 | Q2YD98 | |
| EDEEAAEAEAEAEEA | 381 | O15240 | |
| EEEDDDADDDDDDNN | 1376 | Q02880 | |
| DADDDDDDNNDLEEL | 1381 | Q02880 | |
| NDEDEDEDEDDKDEE | 166 | Q86XG9 | |
| NDEDEDEDEDDKDEE | 166 | Q5VWK0 | |
| RASLDEDEDDDDEED | 336 | Q7Z6M4 | |
| DEAEDNDEDEDDDEE | 366 | Q7Z6M4 | |
| EDDDDLEEDDEDSLA | 1121 | Q9HAZ2 | |
| SEEAENEEDEDDTEE | 286 | O15355 | |
| NEEDEDDTEEAEEDD | 291 | O15355 | |
| YDEDDDDEGEEEEEA | 121 | Q96EB6 | |
| LADASDNEEEEEEEE | 371 | Q9UL54 | |
| NAIEDEEEEEEEDDD | 36 | P13667 | |
| DDFDDVEEDEGLDDL | 11 | P61218 | |
| QGHEEDDDDDDDDDD | 241 | P23327 | |
| DDDDDDDDDDDVSIE | 251 | P23327 | |
| EDKEDEEDEEDDDVS | 321 | O75381 | |
| SEDDYEEEEEDSDED | 951 | Q9Y5B9 | |
| EEEEEAAESEEDDNL | 971 | Q09428 | |
| DDDDEDDDLEDESIS | 376 | Q96AJ1 | |
| SEEDEDEEEDYDDDE | 281 | P52655 | |
| TAVDSEDDDDEEDIE | 81 | Q9Y4G8 | |
| EEEEEEEEEEEAAAA | 761 | Q5TCY1 | |
| SDSDDEDDEEEDEEE | 261 | P04198 | |
| IDSDDEEEDDDENDG | 1946 | P12270 | |
| EEEDDDENDGEHEDY | 1951 | P12270 | |
| EHEDYEEDEEDDDDD | 1961 | P12270 | |
| VAEDEDEEEEAEEAA | 461 | Q96HA7 | |
| AEDDEDDEDEDDEEA | 66 | Q969T3 | |
| DSDLDEDEDEDEEES | 1856 | Q5T1R4 | |
| EDEDEDEEESQDELS | 1861 | Q5T1R4 | |
| EDEQEEAAEEDAEAE | 31 | P45379 | |
| EAAEEDAEAEAETEE | 36 | P45379 | |
| TEDDEDEDDDKEDEV | 421 | Q08629 | |
| DDEDSGAEIEDDDEE | 156 | O43847 | |
| DDDEEGFDDEDEFDD | 166 | O43847 | |
| DEFDDEHDDDLDTED | 176 | O43847 | |
| DLETDVADDDADDEE | 1211 | Q9HCK4 | |
| VADDDADDEEEALEI | 1216 | Q9HCK4 | |
| DDDDDDAAEQEEYDE | 176 | O15318 | |
| QHDEDGIEEEDDDDD | 356 | Q92973 | |
| DDDDDEIDDDDTISD | 366 | Q92973 | |
| EEDDDDDTEDFADQE | 161 | A1YPR0 | |
| VEEEEAAEDSDDDEI | 461 | Q63HK3 | |
| CEDEDSDEDDELDSV | 271 | Q9NRL3 | |
| EDEEDDSEDAINEFD | 306 | Q9NRL3 | |
| YDDDIDDEDEEEEDA | 211 | Q712K3 | |
| DDEDEEEEDADCYDD | 216 | Q712K3 | |
| AEEADEATEEDSDDD | 526 | Q8IWY8 | |
| DESEDGDENEEDDED | 716 | P17480 | |
| AGSALEEDDEDDEED | 406 | Q96SB3 |